Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
72 CHF | -0.14% | +0.56% | +41.06% |
Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.06% | 1.27B | |
+25.95% | 653B | |
+27.00% | 556B | |
-6.45% | 354B | |
+20.44% | 331B | |
+3.79% | 296B | |
+13.04% | 233B | |
+5.57% | 201B | |
-9.61% | 193B | |
-6.29% | 144B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals Secures US FDA's Orphan-drug Designation For Pouchitis Drug